Efficacy of a topical formulation containing eprinomectin, esafoxolaner and praziquantel (NexGard ® Combo) in the treatment of natural respiratory capillariosis of cats
Parasite · 2024
DOI: 10.1051/parasite/2024005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Parasite, 2024. Verfasst von Angela Di Cesare und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine, University of Teramo, Località Piano D'Accio snc, 64100 Teramo, Italy. Hauptthemen laut MEDLINE: Nematode Infections, Enoplida Infections, Cat Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim France.
Abstract (Originalsprache)
Feline pulmonary capillariosis is a significant disorder due to its distribution and clinical impact. This study evaluated the safety and efficacy of two administrations 28 days apart of a topical solution containing esafoxolaner, eprinomectin and praziquantel (NexGard ® Combo) in treating Eucoleus aerophilus (syn. Capillaria aerophila ) infection in naturally infected cats. Cats were allocated to two groups: G1 cats ( n = 23) received two treatments at study days (SDs) 0 and 28 (±2) and were evaluated for 6 weeks, and G2 cats ( n = 17) served as a negative control for 6 weeks and were then treated twice on SDs 42 (±2) and 70 (±2), allowing for an additional 6-week assessment of efficacy. Each cat was subjected to McMaster coproscopy at SDs −7/0, 28 (±2) and 42 (±2) for both groups, 70 (±2) and 84 (±2) only for G2. Clinical examination and chest radiographic images were performed at SDs 0, 28 (±2) and 42 (±2) for G1 and G2, 70 (±2) and 84 (±2) only for G2. The comparison of EPG (eggs per gram of feces), clinical (CS), and radiographic scores (RS) at each time-point was used as a criterion. The efficacy based on the EPG reduction was 99.5% (G1) and 100% (G2) after two administrations of NexGard ® Combo 2 weeks apart. At SD 0, no significant differences for CS and RS were recorded between G1 and G2, while a significant reduction ( p < 0.05) was observed post-treatment for CS, RS, oculo-nasal discharge, auscultation noises, and cough. Two doses of NexGard ® Combo 28 days apart stopped egg shedding and significantly improved clinical alterations in cats infected by E. aerophilus .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Medicine, University of Teramo, Località Piano D'Accio snc, 64100 Teramo, Italy.
- Department of Veterinary Medicine, University of Perugia, Via San Costanzo 4, 06126 Perugia, Italy.
- Boehringer Ingelheim Animal Health, 29 Avenue Tony Garnier, 69007 Lyon, France.
Förderung
- Boehringer Ingelheim France
Zitieren
APA
Di Cesare, A., Morganti, G., Vignoli, M., Colombo, M., Veronesi, F., Bufalari, A., Tielemans, E., Beugnet, F., & Traversa, D. (2024). Efficacy of a topical formulation containing eprinomectin, esafoxolaner and praziquantel (NexGard ® Combo) in the treatment of natural respiratory capillariosis of cats. Parasite. https://doi.org/10.1051/parasite/2024005
Vancouver
Di Cesare A, Morganti G, Vignoli M, Colombo M, Veronesi F, Bufalari A, et al. Efficacy of a topical formulation containing eprinomectin, esafoxolaner and praziquantel (NexGard ® Combo) in the treatment of natural respiratory capillariosis of cats. Parasite. 2024. doi:10.1051/parasite/2024005
BibTeX
@article{DiCesare2024,
author = {Di Cesare, Angela and Morganti, Giulia and Vignoli, Massimo and Colombo, Mariasole and Veronesi, Fabrizia and Bufalari, Antonello and Tielemans, Eric and Beugnet, Frederic and Traversa, Donato},
title = {Efficacy of a topical formulation containing eprinomectin, esafoxolaner and praziquantel (NexGard ® Combo) in the treatment of natural respiratory capillariosis of cats},
journal = {Parasite},
year = {2024},
doi = {10.1051/parasite/2024005}
}
EUVIMED